Strategies for experimental therapy of the retrovirus which causes aids

Baltimore, 1970, RNA-dependent DNA polymerase in virions of RNA tumor viruses, Nature (Lond.), 226, 1209, 10.1038/2261209a0 Dalgleish, 1984, The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature (Lond.), 312, 763, 10.1038/312763a0 Dayton, 1986, The trans-activator gene of the human T-cell lymphotropic virus type III is required for replication, Celt, 44, 941, 10.1016/0092-8674(86)90017-6 Doering, 1966, Polymer synthesis in killed bacteria: lethality of 2′,3′-dideoxyadenosine, J. Bact., 92, 565, 10.1128/JB.92.3.565-574.1966 Fisher, 1986, The trans-activator gene of HTLV-III is essential for virus replication, Nature (Lond.), 320, 367, 10.1038/320367a0 Gallo, 1984, Isolation and characterization of human T-cell leukemia/lymphoma virus, pp. 549–551, Ann. intern. Med., 100, 543 Gallo, 1984, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science, 224, 500, 10.1126/science.6200936 Goswami, 1979, The broad spectrum antiviral agent ribavirin inhibits capping of mRNA, Biochem. biophys. Res. Commun., 89, 830, 10.1016/0006-291X(79)91853-9 Horwitz, 1964, Nucleosides. — V. The monomesylates of l-(2′-deoxy-beta-D-lyxofuranosyl) thymidine, J. org. Chem., 29, 2076, 10.1021/jo01030a546 Horwitz, 1967, Nucleosides. XI. 2′,3′-dideoxycytidine, J. org. Chem., 32, 817, 10.1021/jo01278a070 Izant, 1984, Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analysis, Cell, 36, 1007, 10.1016/0092-8674(84)90050-3 Klatzmann, 1984, T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV, Nature (Lond.), 312, 767, 10.1038/312767a0 Lin, 1978, Synthesis and biological activity of several amino acid analogues of thymidine, J. med. Chem., 21, 109, 10.1021/jm00199a020 McCormick, 1984, Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes, Lancet, II, 1367, 10.1016/S0140-6736(84)92060-9 Mitsuya, 1986, Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides, Proc. nat. Acad. Sci. (Wash.), 83, 1911, 10.1073/pnas.83.6.1911 Mitsuya, 1985, 3′-azido-3′-deoxythymidine (BWA509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro, Proc. nat. Acad. Sci. (Wash.), 82, 7096, 10.1073/pnas.82.20.7096 Murikami, 1985, Characterization of sequence-specific oligodeoxyribonucleoside methylphosphonates and their interaction with rabbit globin mRNA, Biochemistry, 24, 4041, 10.1021/bi00336a036 Ostertag, 1974, Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus, Proc. nat. Acad. Sei. (Wash.), 71, 4980, 10.1073/pnas.71.12.4980 Pestka, 1984, Anti-mRNA: specific inhibition of translation of single mRNA molecules, Proc. nat. Acad. Sci. (Wash.), 81, 7525, 10.1073/pnas.81.23.7525 Poiesz, 1980, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. nat. Acad. Sci. (Wash.), 77, 7415, 10.1073/pnas.77.12.7415 Popovic, 1984, OKT-4 antigen bearing molecule is a receptor for the human retrovirus HTLV-III, Clin. Res., 33, 560 A Popovic, 1984, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS, Science, 224, 497, 10.1126/science.6200935 Robert-Guroff, 1985, HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-reiated complex, Nature (Lond.), 316, 72, 10.1038/316072a0 Robins, 1966, Purine nucleosides. — XII. The preparation of 2′,3′-dideoxyadenosine, 2′,5′-dideoxyadenosine, and 2′,3′,5′-trideoxy-adenosine from 2′-dideoxyadenosine, Biochemistry, 5, 224, 10.1021/bi00865a029 Robins, 1964, The synthesis of 2′–3′-dideoxyadenosine from 2′-deoxyadenosine, J. Amer. chem. Soc., 86, 3585, 10.1021/ja01071a055 Rosen, 1986, Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III, Nature (Lond.), 319, 555, 10.1038/319555a0 Rosen, 1985, The location of the cis-acting regulatory sequences in the human T-cell lymphotopic virus type III (HTLV-III/LAV) long terminal repeat, Cell, 41, 813, 10.1016/S0092-8674(85)80062-3 Sarin, 1985, Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro, New Engl. J. Med., 313, 1289, 10.1056/NEJM198511143132011 Shaw, 1984, Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immunodeficiency syndrome, Science, 226, 1165, 10.1126/science.6095449 Sodroski, 1984, Trans-acting transcriptional activation of the long terminal repeat of human T-lymphotropic viruses in infected cells, Science, 225, 381, 10.1126/science.6330891 Stephenson, 1978, Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide, Proc. nat. Acad. Sci. (Wash.), 75, 285, 10.1073/pnas.75.1.285 Temin, 1970, RNA-directed DNA polymerase in virions in Rous sarcoma virus, Nature (Lond.), 226, 1211, 10.1038/2261211a0 Toji, 1970, Termination of deoxyribonucleic acid in Escherichia coli by 2′,3′-dideoxyadenosine, J. Bact., 103, 323, 10.1128/JB.103.2.323-328.1970 Veronese, 1986, Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV, Science, 231, 1289, 10.1126/science.2418504 Wayne-Hobson, 1986, Genetic structure of the lymphadenopathy-AIDS virus, Cancer Rev., 1, 18 Weiss, 1985, Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients, Nature (Lond.), 316, 69, 10.1038/316069a0 Wickstrom, 1986, Complementary oligonucleotide probe of vescular stomatitis virus matrix protein mRNA translation, Biophys. J., 49, 15, 10.1016/S0006-3495(86)83574-3 Wong-Staal, 1985, Human T-lymphotropic retroviruses, Nature (Lond.), 317, 395, 10.1038/317395a0 Yarchoan, 1986, Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex, Lancet, I, 575, 10.1016/S0140-6736(86)92808-4